Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events

Mia-Jeanne van Rooy, E Pretorius1

  • 1Department of Physiology, Faculty of Health Sciences, University of Pretoria, Private Bag x323, ARCADIA 0007, South Africa. resia.pretorius@up.ac.za.

Current Medicinal Chemistry
|December 31, 2013
PubMed

Insights

Atherosclerosis arises from a combination of risk factors like high cholesterol, hypertension, and inflammation, not a single cause. Understanding these interconnected factors is key to preventing cardiovascular and cerebral complications.

Area of Science:

  • Cardiovascular Science
  • Pathophysiology
  • Medical Research

Background:

  • Atherosclerosis is a prevalent arterial disease.
  • It stems from vascular injury caused by hypercholesterolemia, hypertension, and inflammation.
  • Obesity, hypertension, and hypercholesterolemia are key contributors.

Purpose of the Study:

  • To review the role of various risk factors in atherosclerosis.
  • To explore the interplay between inflammation, reactive oxygen species (ROS), and nitric oxide (NO).
  • To discuss the link between risk factors and ischemic events.

Main Methods:

  • Literature review of atherosclerosis risk factors.
  • Analysis of the role of inflammation and oxidative stress.
  • Correlation of inflammatory cytokines with risk factors.

Main Results:

  • Atherosclerosis results from a combination of risk factors, not a single cause.
  • Inflammation, ROS, and NO play critical roles in disease development.
  • Risk factors contribute to ischemic events like stroke and myocardial infarction.

Conclusions:

  • Atherosclerosis is a multifactorial disease involving complex physiological processes.
  • Individual risk profiles are unique and dictate the likelihood of acute events.
  • Managing combined risk factors is crucial for preventing atherosclerosis complications.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K